WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005123134) A CONTROLLED RELEASE DELIVERY SYSTEM FOR METFORMIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/123134    International Application No.:    PCT/IN2005/000148
Publication Date: 29.12.2005 International Filing Date: 05.05.2005
Chapter 2 Demand Filed:    28.11.2005    
IPC:
A61K 9/20 (2006.01), A61K 31/155 (2006.01), A61P 3/10 (2006.01)
Applicants: CADILA HEALTHCARE LIMITED [IN/IN]; Zydus Tower, Satellite Cross Roads, Ahmedabad 380 015, Gujarat (IN) (For All Designated States Except US).
LOHRAY, Braj, Bhushan [IN/IN]; (IN) (For US Only).
TIWARI, Sandip, B. [IN/IN]; (IN) (For US Only)
Inventors: LOHRAY, Braj, Bhushan; (IN).
TIWARI, Sandip, B.; (IN)
Agent: SUBRAMANIAM, Hariharan; Subramaniam, Nataraj and Associates, E-556 Greater Kailash II, New Delhi 110 048, Maharashtra (IN)
Priority Data:
557/MUM/2004 14.05.2004 IN
Title (EN) A CONTROLLED RELEASE DELIVERY SYSTEM FOR METFORMIN
(FR) SYSTEME D'ADMINISTRATION A LIBERATION CONTROLEE POUR METFORMINE
Abstract: front page image
(EN)The invention relates to a controlled release delivery system for Metformin comprising of (a) therapeutically effective amount of Metformin or pharmaceutically acceptable salts there of; (b) hydrophilic polymers and (c) hydrophobic lubricating agent(s). The invention also relates to a method of making the said solid dosage form.
(FR)Cette invention concerne un système d'administration à libération contrôlée pour Metformine comprenant: (a) une quantité thérapeutiquement efficace de Metformine ou des sels pharmaceutiquement acceptables de celle-ci; (b) des polymères hydrophiles; et (c) un ou plusieurs agents lubrifiants hydrophobes. Cette invention concerne également un procédé de production de cette forme posologique solide.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)